Literature DB >> 3091378

The roles of interleukin 2 and interferon-gamma in human B cell activation, growth and differentiation.

D F Jelinek, J B Splawski, P E Lipsky.   

Abstract

The roles of interleukin 2 (IL 2) and interferon-gamma (IFN-gamma) in human peripheral blood B cell activation, growth and differentiation were examined. Highly purified B cells stimulated with Cowan I Staphylococcus aureus (SA) proliferated minimally and generated no immunoglobulin-secreting cells (ISC) without the addition of T cell supernatants (T sup) produced by mitogen-activated T cells. Recombinant IL 2 (rIL 2) alone was able to promote maximum proliferation and generation of ISC in cultures of highly purified SA-stimulated B cells when present from the initiation of the incubation. IFN-gamma, by contrast, could not support either response alone. When a two-step culture system was employed to determine the effect(s) of T cell influences during both initial activation and in propagating the response following activation, it was found that B cells activated by SA alone subsequently responded maximally to T sup but only minimally to IL 2 and not at all to IFN-gamma. However, the presence of T sup, rIL 2, or rIFN-gamma during initial activation with SA was found to facilitate greatly the subsequent capacity of the activated B cells to proliferate and differentiate in response to either T sup or IL 2. These data suggest two distinct pathways of human B cell responsiveness. Activities in T sup other than IL 2 or IFN-gamma can support the growth and differentiation of B cells initially activated with SA alone, whereas rIL 2 is capable of promoting these responses maximally only when B cells have been initially activated by SA in the presence of T cell lymphokines, such as IL 2 or IFN-gamma. The results emphasize the role of specific T cell factors in determining the outcome of humoral immune responses.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3091378     DOI: 10.1002/eji.1830160809

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  29 in total

1.  Regulation of human B cell proliferation and differentiation by seminal plasma.

Authors:  H K Lee; H H Lee; Y M Park; J H Lee; T Y Ha
Journal:  Clin Exp Immunol       Date:  1991-07       Impact factor: 4.330

2.  Cytokine regulation of immunoglobulin secretion by neonatal lymphocytes.

Authors:  J B Splawski; P E Lipsky
Journal:  J Clin Invest       Date:  1991-09       Impact factor: 14.808

3.  Delineation of the functional capacity of human neonatal lymphocytes.

Authors:  J B Splawski; D F Jelinek; P E Lipsky
Journal:  J Clin Invest       Date:  1991-02       Impact factor: 14.808

4.  Expression of low-density lipoprotein receptors in peripheral blood and tonsil B lymphocytes.

Authors:  J B De Sanctis; I Blanca; H Rivera; N E Bianco
Journal:  Clin Exp Immunol       Date:  1998-08       Impact factor: 4.330

Review 5.  Roles of interferon produced in physiological conditions. A speculative review.

Authors:  V Bocci
Journal:  Immunology       Date:  1988-05       Impact factor: 7.397

6.  Human nasopharyngeal-associated lymphoreticular tissues. Functional analysis of subepithelial and intraepithelial B and T cells from adenoids and tonsils.

Authors:  P N Boyaka; P F Wright; M Marinaro; H Kiyono; J E Johnson; R A Gonzales; M R Ikizler; J A Werkhaven; R J Jackson; K Fujihashi; S Di Fabio; H F Staats; J R McGhee
Journal:  Am J Pathol       Date:  2000-12       Impact factor: 4.307

7.  Eosinophils regulate peripheral B cell numbers in both mice and humans.

Authors:  Tina W Wong; Alfred D Doyle; James J Lee; Diane F Jelinek
Journal:  J Immunol       Date:  2014-03-10       Impact factor: 5.422

8.  Activation of resting human B cells by helper T-cell clone supernatant: characterization of a human B-cell-activating factor.

Authors:  A Diu; M L Gougeon; J L Moreau; E L Reinherz; J Thèze
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

9.  Study of induction of activation of human peripheral blood mononuclear cells with a non-activating form of anti-CD3 MoAb in autoimmune thyroid disease (AITD).

Authors:  E Resetkova; G Arreaza; N Yoshikawa; T Morita; H Kim; P Carayon; R Volpé
Journal:  Clin Exp Immunol       Date:  1993-03       Impact factor: 4.330

10.  Flow cytometric studies of IL-4-stimulated expression of the CD25 antigen by quiescent human B lymphocyte subpopulations.

Authors:  R D Butcher; W Cushley
Journal:  Immunology       Date:  1991-11       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.